BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 25, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 27, 2012
View Archived Issues
Studies assess GS-9620-induced INF-alpha response and antiviral effects
Read More
Soligenix reports thermostability of vaccines using ThermoVax
Read More
U.S. university patents new candidate vaccine adjuvants
Read More
Novel potential vaccines reported for enteroviral infections
Read More
Phase I trial studies vandetanib combination therapy for brain cancer
Read More
Scientists in Europe uncover new recognition factor for HIV-1 entry
Read More
Phase I data available on antisense drug for ALS
Read More
IntelGenx and Redhill Biopharma launch pivotal trial of antimigraine product
Read More
Epizyme forms strategic partnership with Celgene
Read More
Shire reports topline data on drug for binge eating disorder
Read More
Galenea to receive funds from the Stanley Medical Research Institute
Read More
Phase I trial tests once-daily and intermittent INK-128 dosing
Read More
Continuation recommended for trial assessing whipworm egg therapy for Crohn's disease
Read More
Mount Sinai School of Medicine evaluates IGF-1 product in autism subtype
Read More
Omthera Pharmaceuticals reports topline results from EVOLVE study
Read More
Advanced Cell Technology clear to continue Stargardt's macular dystrophy trials
Read More
GlaxoSmithKline files application in Japan for ofatumumab
Read More
Novartis extends oncology discovery research collaboration
Read More
Dynavax files BLA for hepatitis B vaccine
Read More
FDA revises Victrelis label
Read More
Jazz Pharmaceuticals enters acquisition agreement
Read More
Amgen gives update on Xgeva sBLA
Read More
Investigation at Bionature yields novel candidate oncolytics
Read More
Novel DUB/FAF-X inhibitors presented
Read More
InterMune designs novel HCV NS3/NS4A inhibitors
Read More
German university announces novel candidate analgesics
Read More
